These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35854043)

  • 1. Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review.
    Miki K; Shimamura Y; Maeda T; Moniwa N; Ogawa Y; Shimizu T; Hayashi T; Sakai H; Takizawa H
    CEN Case Rep; 2023 Feb; 12(1):56-62. PubMed ID: 35854043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK; Yang AH; Lai HC; Lin BS
    BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalline Light Chain Casts and Hypercalcemia Induced Acute Kidney Injury: A Rare Presentation of Multiple Myeloma.
    Nishigaito T; Mitsumoto K; Katsunuma R; Hirai Y; Yamashita C; Mizumoto A; Uzu T
    Intern Med; 2024 Jun; 63(12):1751-1755. PubMed ID: 37926541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambda light chain - restricted non - crystalline proximal tubulopathy with cast nephropathy in multiple myeloma: a case report and literature review.
    Lan M; Guo Y; Wang C; Wang X; Li J; Wang Y
    BMC Nephrol; 2024 Sep; 25(1):324. PubMed ID: 39350086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
    Hutchison CA; Cockwell P; Moroz V; Bradwell AR; Fifer L; Gillmore JD; Jesky MD; Storr M; Wessels J; Winearls CG; Weisel K; Heyne N; Cook M
    Lancet Haematol; 2019 Apr; 6(4):e217-e228. PubMed ID: 30872075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
    Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
    Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
    Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
    Hada R; Poudyal B; Sharma A; Khatri R
    JNMA J Nepal Med Assoc; 2012; 52(188):192-5. PubMed ID: 23591252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
    Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
    BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.
    Sun LJ; Dong HR; Xu XY; Wang GQ; Cheng H; Chen YP
    BMC Nephrol; 2021 Jan; 22(1):42. PubMed ID: 33509125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
    Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
    CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.
    Gharwan H; Truica CI
    Med Oncol; 2012 Jun; 29(2):1197-201. PubMed ID: 21479696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
    Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
    Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of primary renal allograft dysfunction due to myeloma cast nephropathy.
    Lingaraj U; Vankalakunti M; Radhakrishnan H; Sreedhara CG; Rajanna S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):970-5. PubMed ID: 26354571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
    Bridoux F; Carron PL; Pegourie B; Alamartine E; Augeul-Meunier K; Karras A; Joly B; Peraldi MN; Arnulf B; Vigneau C; Lamy T; Wynckel A; Kolb B; Royer B; Rabot N; Benboubker L; Combe C; Jaccard A; Moulin B; Knebelmann B; Chevret S; Fermand JP;
    JAMA; 2017 Dec; 318(21):2099-2110. PubMed ID: 29209721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.
    Bouchet A; Teuma C; Nouvier M; Rousset P; Javaugue V; Lazareth A; Lombard C; Isaac S; Fouque D
    Am J Kidney Dis; 2019 Nov; 74(5):700-702. PubMed ID: 31155325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
    Lin ZS; Qin AB; Wang SX; Yu XJ; Dong B; Xiong ZY; Chen MH; Zhou FD; Zhao MH
    J Nephrol; 2021 Aug; 34(4):1169-1177. PubMed ID: 33394345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal failure in multiple myeloma: Specific management issues].
    Try M; Harel S
    Bull Cancer; 2024; 111(7-8):733-740. PubMed ID: 36759215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury].
    Rekhtina IG; Kazarina EV; Stolyarevich ES; Kovrigina AM; Dvirnyk VN; Kulikov SM; Mendeleeva LP
    Ter Arkh; 2020 Sep; 92(7):63-69. PubMed ID: 33346446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.